MiMedx Group, Inc.
MiMedx Group, Inc. (MDXG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDXG · as of Jun 8, 2026
Key Statistics
Explore MiMedx Group, Inc. Data
mdxg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 80.0%
The MDXG analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +170.27% upside from the current price of $3.70.
Competitors & Peers
mdxg competitorsMDXG
ATAI
CVAC
DNTH
INBX
INVAStock Performance
Full HistoryAbout MiMedx Group, Inc.
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to…
what is mimedx group, inc. · mdxg stock overview · mimedx group, inc. company profile · who is mimedx group, inc. ceo · mdxg NASDAQ · mimedx group, inc. headquarters · mimedx group, inc. business segments
About Stock Overview & Key Data
MiMedx Group, Inc. (MDXG) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 12, 2008. As of the latest trading session, MDXG stock price is $3.70, with a market capitalization of $551.1M. The stock has returned -41.78% over the past 12 months and -44.53% year-to-date.
According to 15 Wall Street analysts, the consensus rating for MiMedx Group, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, MiMedx Group, Inc. reported revenue of $418.6M and net income of $48.6M. For detailed data — including MiMedx Group, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MiMedx Group, Inc. (MDXG) stock price is $3.70. The stock is traded on NASDAQ under the ticker symbol MDXG. The 52-week range is $3.03 – $7.99.